Health Canada’s proposed amendments to the Food and Drug Regulations and the Medical Devices Regulations
Pharma in Brief
AUGUST 9, 2021
Terms and conditions would be imposed after discussions with the manufacturer and would obligate them to take steps to manage risks and resolve uncertainties. An RMP summarizes the risks of a drug and the pharmacovigilance activities and other measures that a manufacturer puts in place to monitor and manage any identified risks.
Let's personalize your content